Zobrazeno 1 - 4
of 4
pro vyhledávání: '"William Ching-Yuen Chu"'
Autor:
William Ching-Yuen Chu, Lorraine Lok-Wing Chiang, Dorothy Chi-Ching Chan, Wilfred Hing-Sang Wong, Godfrey Chi-Fung Chan
Publikováno v:
Orphanet Journal of Rare Diseases, Vol 15, Iss 1, Pp 1-9 (2020)
Abstract Background We aim to elucidate the disease impact by accounting the prevalence, survival rate, genetics, mTOR inhibitor use and direct costs of tuberous sclerosis complex (TSC) in our local setting. TSC patients with documented visits to our
Externí odkaz:
https://doaj.org/article/36ed7c619c4346359a5986f8ee2ebd2c
Publikováno v:
BMC Sports Science, Medicine and Rehabilitation, Vol 13, Iss 1, Pp 1-8 (2021)
BMC Sports Science, Medicine and Rehabilitation
BMC Sports Science, Medicine and Rehabilitation
Background People with physical disabilities (PWPD) have limited opportunities to participate in sport activities. Sitting light volleyball (SLVB) is an adapted sport that combines light volleyball and paralympic sitting volleyball. This study examin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::96c661fac885f4dce9bd5aee5c13678b
https://doi.org/10.1186/s13102-021-00328-7
https://doi.org/10.1186/s13102-021-00328-7
Autor:
Lorraine Lok-Wing Chiang, William Ching-Yuen Chu, Godfrey Chi-Fung Chan, Coey Cheuk-Yee Chung, Nicole Wing-Lam Hon, Dorothy Chi-Ching Chan, Wilfred Hing Sang Wong
Background:Tuberous sclerosis complex (TSC) is a rare autosomal dominant disorder characterized by benign tumor growth in multiple organs, which may cause significant negative impact on patients’ health-related quality of life (HRQoL). Since HRQoL
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::45477334315acc69b12cbfeff4bbc2ea
https://doi.org/10.21203/rs.3.rs-213821/v1
https://doi.org/10.21203/rs.3.rs-213821/v1
Autor:
Ying Mao, Zhi feng Shi, William Ching Yuen Chu, Ho Keung Ng, Wen cai Li, Wai Sang Poon, Gopika Punchhi, Rui Ryan Yang, Abudumijiti Aibaidula, Kay Ka Wai Li, Zhen-Yu Zhang, Nellie Yuk Fei Chung, Johnny S. H. Kwan, Xian zhi Liu, Wei wei Wang, Ivan Sik Hei Chan, Aden Ka-Yin Chan, Hong Chen
Publikováno v:
Brain Pathol
In the 2016, WHO classification of tumors of the central nervous system, isocitrate dehydrogenase (IDH) mutation is a main classifier for lower grade astrocytomas and IDH-mutated astrocytomas is now regarded as a single group with longer survival. Ho
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e4fed2c92ff43f0b5a0045dbe5d6a652
https://pubmed.ncbi.nlm.nih.gov/31733156
https://pubmed.ncbi.nlm.nih.gov/31733156